These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37269436)

  • 21. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease.
    Miyatake S; Miyake N; Touho H; Nishimura-Tadaki A; Kondo Y; Okada I; Tsurusaki Y; Doi H; Sakai H; Saitsu H; Shimojima K; Yamamoto T; Higurashi M; Kawahara N; Kawauchi H; Nagasaka K; Okamoto N; Mori T; Koyano S; Kuroiwa Y; Taguri M; Morita S; Matsubara Y; Kure S; Matsumoto N
    Neurology; 2012 Mar; 78(11):803-10. PubMed ID: 22377813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans.
    Park MG; Shin JH; Lee SW; Park HR; Park KP
    J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moyamoya vasculopathy shows a genetic mutational gradient decreasing from East to West.
    Raso A; Biassoni R; Mascelli S; Nozza P; Ugolotti E; Di Marco E; De Marco P; Merello E; Cama A; Pavanello M; Capra V
    J Neurosurg Sci; 2020 Apr; 64(2):165-172. PubMed ID: 27787485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between RNF213 c.14576G>A Variant (rs112735431) and Peripheral Pulmonary Artery Stenosis in Moyamoya Disease.
    Ozaki D; Endo H; Tashiro R; Sugimura K; Tatebe S; Yasuda S; Tomata Y; Endo T; Tominaga K; Niizuma K; Fujimura M; Tominaga T
    Cerebrovasc Dis; 2022; 51(3):282-287. PubMed ID: 34710878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
    Liao X; Deng J; Dai W; Zhang T; Yan J
    Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective Screening of Extracranial Systemic Arteriopathy in Young Adults with Moyamoya Disease.
    Jee TK; Yeon JY; Kim SM; Bang OY; Kim JS; Hong SC
    J Am Heart Assoc; 2020 Oct; 9(19):e016670. PubMed ID: 32954918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Genetic Variants with Postoperative Donor Artery Development in Moyamoya Disease: RNF213 and Other Moyamoya Angiopathy-Related Gene Analysis.
    Torazawa S; Miyawaki S; Imai H; Hongo H; Ono H; Ogawa S; Sakai Y; Kiyofuji S; Koizumi S; Komura D; Katoh H; Ishikawa S; Saito N
    Transl Stroke Res; 2024 Apr; ():. PubMed ID: 38592555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNF213 Rare Variants in Slovakian and Czech Moyamoya Disease Patients.
    Kobayashi H; Brozman M; Kyselová K; Viszlayová D; Morimoto T; Roubec M; Školoudík D; Petrovičová A; Juskanič D; Strauss J; Halaj M; Kurray P; Hranai M; Harada KH; Inoue S; Yoshida Y; Habu T; Herzig R; Youssefian S; Koizumi A
    PLoS One; 2016; 11(10):e0164759. PubMed ID: 27736983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of RNF213 c.14576G>A Variant on the Development of Direct and Indirect Revascularization in Pediatric Moyamoya Disease.
    Kawabori M; Ito M; Kazumata K; Tokairin K; Hatanaka KC; Ishikawa S; Houkin K; Fujimura M
    Cerebrovasc Dis; 2023; 52(2):171-176. PubMed ID: 36063804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation and Extension Study Exploring the Role of RNF213 p.R4810K in 2,877 Chinese Moyamoya Disease Patients.
    Wang Y; Zhang Z; Wang X; Zou Z; Ta N; Hao F; Yang Y; Li D; Liang M; Han C; Bao X; Ou L; Wang H; Yang Z; Yang R; Zeng F; Shang M; Nie F; Liu W; Duan L
    J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106071. PubMed ID: 34482123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of the moyamoya-related RNF213 p.Arg4810Lys variant in 1,516 Korean individuals.
    Jang MA; Shin S; Yoon JH; Ki CS
    BMC Med Genet; 2015 Nov; 16():109. PubMed ID: 26590131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic analysis of
    Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T
    Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275
    [No Abstract]   [Full Text] [Related]  

  • 33. Association between p.R4810K Variant and Postoperative Collateral Formation in Patients with Moyamoya Disease.
    Ge P; Ye X; Liu X; Deng X; Wang J; Wang R; Zhang Y; Zhang D; Zhang Q; Zhao J
    Cerebrovasc Dis; 2019; 48(1-2):77-84. PubMed ID: 31578010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease.
    Moteki Y; Onda H; Kasuya H; Yoneyama T; Okada Y; Hirota K; Mukawa M; Nariai T; Mitani S; Akagawa H
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25964206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.
    Wu Z; Jiang H; Zhang L; Xu X; Zhang X; Kang Z; Song D; Zhang J; Guan M; Gu Y
    PLoS One; 2012; 7(10):e48179. PubMed ID: 23110205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of rare variants in RNF213 with severe progression of intracranial artery stenosis in quasi-moyamoya disease.
    Torazawa S; Miyawaki S; Imai H; Hongo H; Ishigami D; Shimizu M; Sakai Y; Ogawa S; Kiyofuji S; Koizumi S; Komura D; Katoh H; Ono H; Nakatomi H; Ishikawa S; Saito N
    J Neurosurg; 2024 Sep; ():1-10. PubMed ID: 39270321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of the association between RNF213 polymorphisms and clinical features of moyamoya disease in Asian population.
    Jiang X; Liu L; Ai S; Xie X; Deng J; Jiang Z; Teng B; Liu C; Huang H
    Clin Neurol Neurosurg; 2023 Aug; 231():107801. PubMed ID: 37267801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease.
    Kanoke A; Fujimura M; Niizuma K; Fujimura T; Kakizaki A; Ito A; Sakata H; Sato-Maeda M; Kure S; Tominaga T
    Brain Res; 2016 Jul; 1642():1-9. PubMed ID: 26972532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients.
    Hara S; Mukawa M; Akagawa H; Thamamongood T; Inaji M; Tanaka Y; Maehara T; Kasuya H; Nariai T
    J Neurosurg Pediatr; 2022 Jan; 29(1):48-56. PubMed ID: 34624841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renovascular hypertension and
    Kim JY; Cho H
    Clin Nephrol; 2021 Aug; 96(2):105-111. PubMed ID: 33769276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.